Senores Pharmaceuticals Limited has informed the Exchange regarding a Media release dated October 29, 2026

Summary by 6ix AI

The release highlights robust financial and operational performance, including significant revenue and EBITDA growth compared to the previous year. The company reported strong growth across its business segments and an expansion of its product portfolio, indicating a positive outlook for future performance. The Managing Director emphasized the company's consistent growth and operational excellence, projecting continued revenue and profit growth for the upcoming fiscal year.

Written by 6ix AI from the company’s filing. How 6ix writes summaries